Answers are grounded in this paper and cite their sources.
Demonstrates a new method for quantifying andrographolide in rat plasma, suggesting improved drug detection techniques.
In this study, a simple high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) method has been developed for quantification of andrographolide in rat plasma using andrographolide-lithium adduct as the precursor ion for the first time. The addition of lithium carbonate into the mobile phase could increase the mass response of andrographolide by approximately 100-fold. The analytes were retained and separated on a C18 column and analyzed using a triple quadrupole mass spectrometer equipped with an ESI source. Andrographolide exhibited excellent retention on the C18 column under optimized chromatographic conditions. A simple protein precipitation pretreatment resulted in high extraction recovery (approximately 100%) and negligible matrix effects. The method was linear over the concentration range of 2.00-1606.00 ng/mL. Both precision and accuracy were within acceptable limits. This simple HPLC-MS/MS method has been validated and successfully applied to support pharmacokinetic studies of andrographolide in Sprague-Dawley rats. The present study also provided a strategy for improving the mass response of drugs with low ionization efficiency, especially compounds from plants.
No takes yet. Share an insight, caveat, or question.
Lei et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: